Determination of Serum Insulin-Like Growth Factor and Their Binding Protein-3 in Liver Cirrhosis and Their Clinical Significances

吴云林,叶静,张曙,钟捷,奚容平,郑志存,杨列,林敏,屈仁义

DOI: https://doi.org/10.3760/j.issn:0254-1432.2002.10.007

2002-01-01

Abstract:Objective To investigate the relationship between insulin like growth factor (IGF Ⅰ)、IGF Ⅱ and IGFBP 3 and Child Pugh classification in patients with liver cirrhosis and to determine the potential clinical markers of functional hepatic reserves. Methods Forty four patients with posthepatitic cirrhosis were divided into 3 groups according to disease severity (Child Pugh Score) and 38 healthy subjects severed as controls. Serum levels of IGF Ⅰ, IGF Ⅱ and IGFBP 3 were measured in these groups by immunoradiometric assay. Results Baseline IGF Ⅰ, IGF Ⅱ and IGFBP 3 levels were significantly lower in patients with cirrhosis than in controls, and the serum concentrations of IGF Ⅰ, IGF Ⅱ and IGFBP 3 were associated with the marked changes of liver function due to Child Pugh score. They all showed a significant correlation with the degree of hepatic dysfunction and dropped markedly during the progression of liver failure. The sensitivity of IGF Ⅱ is much higher than that of IGF Ⅰ and IGFBP 3. It was found that IGF Ⅰ30 ng/ml, IGF Ⅱ200 ng/ml, and IGFBP 36 ng/ml might be true predictors of a negative prognosis in patients with liver cirrhosis. Conclusions Serum IGF Ⅰ, IGF Ⅱ and IGFBP 3 may provide new markers in the assessment of liver function, and more importantly, the results indicate that the combination of IGF Ⅰ, IGF Ⅱ and IGFBP 3 with the Child Pugh score is more effective in predicting prognosis than the Child Pugl score alone.